1 / 8

Pancreatic Cancer Therapy Market Competitive Strategy Analysis

The pancreatic cancer therapy market is expected to reach US$ 4056.4 million by 2025 from US$ 2011.2 million in 2017; it is estimated to grow at a CAGR of 8.1% from 2018 to 2025.<br><br>Read More:- https://www.theinsightpartners.com/reports/pancreatic-cancer-therapy-market

Karan45
Download Presentation

Pancreatic Cancer Therapy Market Competitive Strategy Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pancreatic Cancer Therapy Market Global Analysis and Forecast to 2025 Published Date : Aug 2018 Email: sales@theinsightpartners.com

  2. Email: sales@theinsightpartners.com Report Studies ▪ Pancreatic Cancer Therapy Market to 2025 - Global Analysis and Forecasts By Type (Endocrine Pancreatic Cancer and Exocrine Pancreatic Cancer), Therapy (Biology, Chemotherapy and Others) and Geography 2

  3. Email: sales@theinsightpartners.com $50,000 Pancreatic Cancer Therapy Market Value $40,000 $30,000 CAGR of 8.1% $20,000 (2018 to 2025) $10,000 $0 20XX 20XX 20XX 20XX 20XX 3

  4. Email: sales@theinsightpartners.com Pancreatic Cancer Therapy Market Overview ▪ The pancreatic cancer therapy market is expected to reach US$ 4056.4 million by 2025 from US$ 2011.2 million in 2017; it is estimated to grow at a CAGR of 8.1% from 2018 to 2025. ▪ Global pancreatic cancer therapy market, based on the type was segmented into endocrine pancreatic cancer and exocrine pancreatic cancer. In 2017, the exocrine pancreatic cancer segment held the largest share of the market, by type. The exocrine pancreatic cancer segment is expected to grow at the fastest rate during the coming years as this cancer is majorly occurring cancer type among the two and thus is expected to have massive patient pool over the forecast years. 4

  5. Email: sales@theinsightpartners.com Key Segment Market Segment By Type:- ▪ Type (Endocrine Pancreatic Cancer and Exocrine Pancreatic Cancer) ▪ Therapy (Biology, Chemotherapy and Others) 5

  6. Email: sales@theinsightpartners.com Company Profiles ▪ Eli Lilly and Company ▪ F. Hoffmann-La Roche Ltd ▪ Amgen Inc ▪ Novartis AG ▪ Celgene Corporation ▪ Merck & Co., Inc ▪ Pharmacyte Biotech Inc ▪ Clovis Oncology ▪ Teva Pharmaceutical Industries Ltd ▪ Pfizer Inc 6 Download Sample Here

  7. Email: sales@theinsightpartners.com By Geography ▪ North America (the US, Canada, and Mexico) ▪ Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) ▪ Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) ▪ Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) ▪ South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7

  8. THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related